ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech
ERYTECH Announces the A vailability of its H alf- Y ear F inancial R eport 202 1
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 20 2 1
ERYTECH t o Host on September 21, 2021 Second Quarter 2021 conference call and Business Update
ERYTECH to Present at the H.C. Wainwright 23 rd Annual Global Investment Conference
ERYTECH to Participate in the Citi 16 th Annual BioPharma Conference
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
Papyrus Therapeutics Inc. is delighted to announce that two new members have joined our Board of Directors, Marc Beer as chairman and Professor James Lorens PhD as an independent director.